What The Pandemic Can Teach Us About Running Clinical Trials

Lessons For Study Design, Analysis & EU Harmonization

Participants in a recent webinar looked at how the coronavirus is changing the way we look at clinical trials and whether new EU COVID-19 guidance might hold lessons for future approaches to study design.

Experience during the COVID-19 pandemic should help to guide companies and regulators towards new ways of approaching clinical trials, with more use of novel study design, remote site monitoring, and wider use of digital technology, industry speakers said during a webinar this week organized by the European pharma industry body EFPIA.

Representatives of pharmaceutical companies and the European Commission said experience during the pandemic might also help to spur greater harmonization...